• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异常的 ALOX5 激活与 HER2 状态相关,并通过多种机制介导乳腺癌的生物学活性。

Aberrant ALOX5 Activation Correlates with HER2 Status and Mediates Breast Cancer Biological Activities through Multiple Mechanisms.

机构信息

Department of Breast Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi 530021, China.

出版信息

Biomed Res Int. 2020 Nov 10;2020:1703531. doi: 10.1155/2020/1703531. eCollection 2020.

DOI:10.1155/2020/1703531
PMID:33224971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7673939/
Abstract

Arachidonate lipoxygenases (ALOX) have been implicated in playing a critical role in tumorigenesis, development, and metastasis. We previously reported that ALOX12 is involved in breast cancer chemoresistance. In this study, we demonstrate that the ALOX5 activation correlates with the HER2 expression and mediates breast cancer growth and migration. We found that the ALOX5 expression and activity were upregulated in breast cancer patients, particularly in those tissues with HER2-positive. ALOX5 upregulation was also observed in HER2-positive breast cancer cells. In contrast, HER2 inhibition led to decreased expression and activity of ALOX5 but not ALOX5AP, suggesting that HER2 specifically regulates the ALOX5 expression and activity in breast cancer cells. We further demonstrated that ALOX5 is important for breast cancer biological activities with the predominant roles in growth and migration, likely through RhoA, focal adhesion, and PI3K/Akt/mTOR signaling but not epithelial mesenchymal transition (EMT). Our work is the first to report a correlation between the ALOX5 activity and HER2 overexpression in breast cancer. Our findings also highlight the therapeutic value of inhibiting ALOX5 in breast cancer, particularly those patients with the HER2 overexpression.

摘要

花生四烯酸脂加氧酶(ALOX)在肿瘤发生、发展和转移中起着关键作用。我们之前的研究报告称,ALOX12 参与了乳腺癌的化疗耐药性。在这项研究中,我们证明了 ALOX5 的激活与 HER2 的表达相关,并介导了乳腺癌的生长和迁移。我们发现,在乳腺癌患者中,尤其是在 HER2 阳性的组织中,ALOX5 的表达和活性上调。在 HER2 阳性的乳腺癌细胞中也观察到 ALOX5 的上调。相比之下,HER2 的抑制导致 ALOX5 的表达和活性降低,但 ALOX5AP 不受影响,这表明 HER2 特异性调节乳腺癌细胞中 ALOX5 的表达和活性。我们进一步证明,ALOX5 对于乳腺癌的生物学活性很重要,其在生长和迁移方面的作用更为突出,可能是通过 RhoA、焦点黏附以及 PI3K/Akt/mTOR 信号通路,但不是上皮间质转化(EMT)。我们的工作首次报道了 ALOX5 活性与乳腺癌中 HER2 过表达之间的相关性。我们的研究结果还突出了抑制 ALOX5 在乳腺癌中的治疗价值,尤其是在那些 HER2 过表达的患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d8/7673939/25dbf08392a5/BMRI2020-1703531.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d8/7673939/2cfe4a9ef012/BMRI2020-1703531.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d8/7673939/55be89800d1b/BMRI2020-1703531.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d8/7673939/355a93a7360e/BMRI2020-1703531.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d8/7673939/25dbf08392a5/BMRI2020-1703531.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d8/7673939/2cfe4a9ef012/BMRI2020-1703531.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d8/7673939/55be89800d1b/BMRI2020-1703531.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d8/7673939/355a93a7360e/BMRI2020-1703531.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d8/7673939/25dbf08392a5/BMRI2020-1703531.004.jpg

相似文献

1
Aberrant ALOX5 Activation Correlates with HER2 Status and Mediates Breast Cancer Biological Activities through Multiple Mechanisms.异常的 ALOX5 激活与 HER2 状态相关,并通过多种机制介导乳腺癌的生物学活性。
Biomed Res Int. 2020 Nov 10;2020:1703531. doi: 10.1155/2020/1703531. eCollection 2020.
2
Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells.PI3K/Akt/mTOR 通路抑制剂联合治疗克服了 PIK3CA 突变型 HER2 阳性乳腺癌细胞对抗 HER2 治疗的耐药性。
Sci Rep. 2020 Dec 10;10(1):21762. doi: 10.1038/s41598-020-78646-y.
3
Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer.HER2 稳定的钠-葡萄糖协同转运蛋白 1(SGLT1)通过激活 HER2+乳腺癌中的 PI3K/Akt/mTOR 信号通路促进乳腺癌细胞增殖。
Dis Markers. 2020 Apr 21;2020:6103542. doi: 10.1155/2020/6103542. eCollection 2020.
4
Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.雌激素对HER2过表达、雌激素受体阳性乳腺癌细胞中趋化因子受体CXCR4的转录后调控
Breast Cancer Res Treat. 2009 Sep;117(2):243-51. doi: 10.1007/s10549-008-0186-z. Epub 2008 Sep 19.
5
HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.HER2/EGFR-AKT 信号转导将 TGFβ 从抑制细胞增殖转变为促进乳腺癌细胞迁移。
Cancer Res. 2018 Nov 1;78(21):6073-6085. doi: 10.1158/0008-5472.CAN-18-0136. Epub 2018 Aug 31.
6
Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells.上调乳腺癌耐药蛋白通过 MCF7 乳腺癌细胞中的 PI3K/Akt 和核因子-κB 信号通路在 HER2 介导的化疗耐药中发挥作用。
Acta Biochim Biophys Sin (Shanghai). 2011 Aug;43(8):647-53. doi: 10.1093/abbs/gmr050. Epub 2011 Jun 28.
7
Transcriptional repression of human epidermal growth factor receptor 2 by ClC-3 Cl /H transporter inhibition in human breast cancer cells.氯离子通道/氢钾离子转运体抑制物抑制人乳腺癌细胞中人类表皮生长因子受体 2 的转录。
Cancer Sci. 2018 Sep;109(9):2781-2791. doi: 10.1111/cas.13715. Epub 2018 Jul 28.
8
Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells.Gab2基因敲除可逆转HER2过表达乳腺癌细胞的干性。
Cell Physiol Biochem. 2018;50(1):52-65. doi: 10.1159/000493957. Epub 2018 Oct 16.
9
Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways.人表皮生长因子受体2通过AKT和丝裂原活化蛋白激酶途径调节乳腺癌中血管生成素-2的表达。
Cancer Res. 2007 Feb 15;67(4):1487-93. doi: 10.1158/0008-5472.CAN-06-3155.
10
Inhibition of arachidonate lipoxygenase12 targets lung cancer through inhibiting EMT and suppressing RhoA and NF-κB activity.花生四烯酸脂加氧酶 12 的抑制作用通过抑制 EMT 以及抑制 RhoA 和 NF-κB 的活性来靶向肺癌。
Biochem Biophys Res Commun. 2020 Apr 16;524(4):803-809. doi: 10.1016/j.bbrc.2020.01.166. Epub 2020 Feb 7.

引用本文的文献

1
Exploration potential sepsis-ferroptosis mechanisms through the use of CETSA technology and network pharmacology.通过使用细胞热位移分析技术和网络药理学探索潜在的脓毒症-铁死亡机制。
Sci Rep. 2025 Apr 19;15(1):13527. doi: 10.1038/s41598-025-95451-7.
2
Predicting the clinical prognosis of non-small cell lung cancer patients by predicting ALOX5 expression: a radiomics model.通过预测ALOX5表达来预测非小细胞肺癌患者的临床预后:一种放射组学模型
J Thorac Dis. 2025 Mar 31;17(3):1387-1399. doi: 10.21037/jtd-24-1596. Epub 2025 Mar 27.
3
A Review Unveiling the Ferroptosis-Regulated Cell Signalling Pathways in Breast Cancer to Elucidate Potent Targets for Cancer Management.

本文引用的文献

1
ALOX12 inhibition sensitizes breast cancer to chemotherapy via AMPK activation and inhibition of lipid synthesis.ALOX12 抑制通过激活 AMPK 和抑制脂质合成使乳腺癌对化疗敏感。
Biochem Biophys Res Commun. 2019 Jun 18;514(1):24-30. doi: 10.1016/j.bbrc.2019.04.101. Epub 2019 Apr 20.
2
Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases.2018 年 ASCO/CAP 指南更新对浸润性乳腺癌 HER2 FISH 检测的影响:2233 例 HER2 FISH 结果的回顾性研究。
Breast Cancer Res Treat. 2019 May;175(1):51-57. doi: 10.1007/s10549-019-05148-5. Epub 2019 Feb 2.
3
一项揭示乳腺癌中受铁死亡调节的细胞信号通路以阐明癌症治疗有效靶点的综述。
Curr Pharm Des. 2025 Jan 31. doi: 10.2174/0113816128343266241230045019.
4
YTHDF1-regulated ALOX5 in retinal pigment epithelial cells under hypoxia enhances VEGF expression and promotes viability, migration, and angiogenesis of vascular endothelial cells.缺氧状态下视网膜色素上皮细胞中的 YTHDF1 调控 ALOX5 增强 VEGF 表达并促进血管内皮细胞的活力、迁移和血管生成。
Sci Rep. 2024 Oct 5;14(1):23226. doi: 10.1038/s41598-024-72388-x.
5
Oxidative cell death in cancer: mechanisms and therapeutic opportunities.癌症中的氧化细胞死亡:机制与治疗机遇
Cell Death Dis. 2024 Aug 1;15(8):556. doi: 10.1038/s41419-024-06939-5.
6
Quercetin Alleviates LPS-Stimulated Myocardial Injury through Regulating ALOX5/PI3K/AKT Pathway in Sepsis.槲皮素通过调节脂氧合酶 5/PI3K/AKT 通路缓解脓毒症诱导的心肌损伤。
Cardiovasc Toxicol. 2024 Oct;24(10):1116-1124. doi: 10.1007/s12012-024-09901-1. Epub 2024 Jul 28.
7
Osteomesopyknosis associated with a novel ALOX5 variant that impacts the RANKL pathway.与影响 RANKL 通路的新型 ALOX5 变异相关的骨硬化性纤维发育不良。
Mol Genet Genomic Med. 2024 May;12(5):e2471. doi: 10.1002/mgg3.2471.
8
Transforming growth factor-induced gene TGFBI is correlated with the prognosis and immune infiltrations of breast cancer.转化生长因子诱导基因 TGFBI 与乳腺癌的预后和免疫浸润相关。
World J Surg Oncol. 2024 Jan 20;22(1):22. doi: 10.1186/s12957-024-03301-z.
9
Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis.乳腺癌中铁死亡的机制及天然化合物调控铁死亡的研究进展。
J Cell Mol Med. 2024 Jan;28(1):e18044. doi: 10.1111/jcmm.18044. Epub 2023 Dec 22.
10
Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.ALOX5 在非小细胞肺癌中的作用:与免疫细胞浸润相关的潜在治疗靶点。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Mar 28;48(3):311-322. doi: 10.11817/j.issn.1672-7347.2023.220427.
5-Lipoxygenase: Its involvement in gastrointestinal malignancies.
5-脂氧合酶:其在胃肠道恶性肿瘤中的作用。
Crit Rev Oncol Hematol. 2018 Jul;127:50-55. doi: 10.1016/j.critrevonc.2018.05.012. Epub 2018 May 18.
4
The importance of 15-lipoxygenase inhibitors in cancer treatment.15-脂氧合酶抑制剂在癌症治疗中的重要性。
Cancer Metastasis Rev. 2018 Sep;37(2-3):397-408. doi: 10.1007/s10555-018-9738-9.
5
Eicosanoid signaling in carcinogenesis of colorectal cancer.类二十烷酸信号在结直肠癌发生中的作用。
Cancer Metastasis Rev. 2018 Sep;37(2-3):257-267. doi: 10.1007/s10555-018-9739-8.
6
HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3.肿瘤中 HER2 的扩增会激活 PI3K/Akt 信号通路,而不依赖于 HER3。
Cancer Res. 2018 Jul 1;78(13):3645-3658. doi: 10.1158/0008-5472.CAN-18-0430. Epub 2018 May 14.
7
Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer.晚期乳腺癌或卵巢癌患者的化疗剂量强度与总生存期。
Clin Breast Cancer. 2018 Oct;18(5):380-386. doi: 10.1016/j.clbc.2018.02.003. Epub 2018 Feb 16.
8
β-Glucosidase inhibition sensitizes breast cancer to chemotherapy.β-葡萄糖苷酶抑制使乳腺癌对化疗敏感。
Biomed Pharmacother. 2017 Jul;91:504-509. doi: 10.1016/j.biopha.2017.04.113. Epub 2017 May 4.
9
Neoadjuvant Therapy for HER2-positive Breast Cancer.HER2阳性乳腺癌的新辅助治疗
Rev Recent Clin Trials. 2017;12(2):81-92. doi: 10.2174/1574887112666170202165049.
10
Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway.癌细胞与肿瘤微环境之间的相互作用:5-脂氧合酶途径的作用
Int J Mol Sci. 2017 Jan 24;18(2):236. doi: 10.3390/ijms18020236.